Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English
  • Portuguese

Education

Medical School

University of Sao Paulo

1985, Brazil

Internship

Hospital of Clinics of the University of Sao Paulo Medical School

1986, San Paulo, Brazil

Residency

Hospital of Clinics / Children's Hospital of the University of Sao Paulo Medical School

1991, San Paulo, Brazil

Fellowship

Boston Children's Hospital

1997, Boston, MA

Fellowship

Boston Children's Hospital

2000, Boston, MA

Professional History

Dario Fauza received MD and PhD degrees from the University of Sao Paulo, in Brazil, where he also attended internship and residencies in general and pediatric surgery. He then moved to the United States in the 1990’s, where he completed further training in different clinical and postdoctoral fellowships, all at Boston Children's Hospital and Harvard Medical School. He is currently a staff member of Boston Children's Hospital’s Department of Surgery and Fetal Care and Surgery Center, as well as an Associate Professor of Surgery at Harvard Medical School.

He has a prolific bibliography and is the recipient of multiple awards and honors in the United States and abroad. He has pioneered novel cell-based strategies for the treatment of congenital diseases, including the principles of fetal tissue engineering in parallel to gestation and of transamniotic stem cell therapy (TRASCET), among others. He has an extensive record of mentoring surgical trainees who went on to successful careers in Pediatric Surgery.

Publications

  1. Bidirectional Feto-Maternal Traffic of Donor Mesenchymal Stem Cells Following Transamniotic Stem Cell Therapy (TRASCET). J Pediatr Surg. 2024 Feb; 59(2):290-294. View Abstract

  2. Morphometric, Developmental, and Anti-Inflammatory Effects of Transamniotic Stem Cell Therapy (TRASCET) on the Fetal Heart and Lungs in a Model of Intrauterine Growth Restriction. Stem Cells Dev. 2023 08; 32(15-16):484-490. View Abstract

  3. Hematogenous Routing of Exogenous Messenger RNA Delivered Into the Amniotic Fluid. J Surg Res. 2023 09; 289:116-120. View Abstract

  4. Fetal Secretory IgA Delivery via Transamniotic Fetal Immunotherapy (TRAFIT) in a Rodent Model. J Pediatr Surg. 2023 Oct; 58(10):2050-2053. View Abstract

  5. Transamniotic stem cell therapy (TRASCET): An emerging minimally invasive strategy for intrauterine stem cell delivery. Semin Perinatol. 2023 04; 47(3):151728. View Abstract

  6. Transamniotic Fetal Administration of Genetically Modified Hematopoietic Stem Cells Carrying a Human Transgene in a Syngeneic Rat Model. Stem Cells Dev. 2023 04; 32(7-8):180-184. View Abstract

  7. Invited Commentary for Disruption of Enterohepatic Circulation of Bile Acids Ameliorates Small Bowel Resection Associated Hepatic Injury. J Pediatr Surg. 2023 06; 58(6):1079-1080. View Abstract

  8. Fetal Alloimmune Hemolytic Anemia (AHA) as a Potential Target for Transamniotic Fetal Immunotherapy (TRAFIT). J Pediatr Surg. 2023 Jun; 58(6):1107-1110. View Abstract

  9. Transamniotic stem cell therapy (TRASCET) for intrauterine growth restriction (IUGR): A comparison between placental and amniotic fluid donor mesenchymal stem cells. J Pediatr Surg. 2023 Feb; 58(2):305-309. View Abstract

  10. Brain protection by transamniotic stem cell therapy (TRASCET) in a model of intrauterine growth restriction (IUGR). J Pediatr Surg. 2023 Jan; 58(1):3-7. View Abstract

  11. Early functional analysis on the pulmonary hemodynamic effects of Transamniotic Stem Cell Therapy (TRASCET) in the nitrofen model of congenital diaphragmatic hernia. J Pediatr Surg. 2023 Jan; 58(1):8-13. View Abstract

  12. Invited Commentary. J Am Coll Surg. 2022 06 01; 234(6):1019-1020. View Abstract

  13. Routing kinetics of human immunoglobulin-G after transamniotic fetal immunotherapy (TRAFIT) in a rodent model. J Pediatr Surg. 2022 Jun; 57(6):1004-1007. View Abstract

  14. Intrauterine Growth Restriction (IUGR) as a potential target for transamniotic stem cell therapy. J Pediatr Surg. 2022 Jun; 57(6):999-1003. View Abstract

  15. Routing pathway of syngeneic donor hematopoietic stem cells after simple intra-amniotic delivery. J Pediatr Surg. 2022 Jun; 57(6):986-990. View Abstract

  16. Passive perinatal immunotherapy via transamniotic antibody delivery. J Pediatr Surg. 2022 Jan; 57(1):52-55. View Abstract

  17. Wound healing potential of human umbilical cord mesenchymal stem cell conditioned medium: An in vitro and in vivo study in diabetes-induced rats. Vet World. 2021 Aug; 14(8):2109-2117. View Abstract

  18. Unselected CD117 expression in amniotic and placental mesenchymal stem cells. J Pediatr Surg. 2021 Dec; 56(12):2410-2411. View Abstract

  19. Transamniotic Stem Cell Therapy for Experimental Congenital Diaphragmatic Hernia: Structural, Transcriptional, and Cell Kinetics Analyses in the Nitrofen Model. Fetal Diagn Ther. 2021; 48(5):381-391. View Abstract

  20. Enhancement of transamniotic stem cell therapy for spina bifida by genetic engineering of donor mesenchymal stem cells with an Fgf2 transgene. J Pediatr Surg. 2021 Jun; 56(6):1226-1232. View Abstract

  21. Fetal hematogenous routing of a donor hematopoietic stem cell line in a healthy syngeneic model of transamniotic stem cell therapy. J Pediatr Surg. 2021 Jun; 56(6):1233-1236. View Abstract

  22. A novel two-component, expandable bioadhesive for exposed defect coverage: Applicability to prenatal procedures. J Pediatr Surg. 2021 Jan; 56(1):165-169. View Abstract

  23. Initial Mechanistic Screening of Transamniotic Stem Cell Therapy in the Rodent Model of Spina Bifida: Host Bone Marrow and Paracrine Activity. Fetal Diagn Ther. 2020; 47(12):902-911. View Abstract

  24. Hematogenous Donor Cell Routing Pathway After Transamniotic Stem Cell Therapy. Stem Cells Dev. 2020 06 15; 29(12):755-760. View Abstract

  25. Postnatal fate of donor mesenchymal stem cells after transamniotic stem cell therapy in a healthy model. J Pediatr Surg. 2020 Jun; 55(6):1113-1116. View Abstract

  26. Transamniotic Stem Cell Therapy. Adv Exp Med Biol. 2020; 1237:61-74. View Abstract

  27. Donor mesenchymal stem cell kinetics after transamniotic stem cell therapy (TRASCET) in a rodent model of gastroschisis. J Pediatr Surg. 2020 Mar; 55(3):482-485. View Abstract

  28. Congenital diaphragmatic hernia as a potential target for transamniotic stem cell therapy. J Pediatr Surg. 2020 Feb; 55(2):249-252. View Abstract

  29. A comparison between placental and amniotic mesenchymal stem cells in transamniotic stem cell therapy for experimental gastroschisis. J Pediatr Surg. 2020 Jan; 55(1):49-53. View Abstract

  30. An experimental study on magnetic esophageal compression anastomosis in piglets. J Pediatr Surg. 2020 Mar; 55(3):425-432. View Abstract

  31. Transamniotic stem cell therapy (TRASCET) in a rabbit model of spina bifida. J Pediatr Surg. 2019 Feb; 54(2):293-296. View Abstract

  32. A comparison of clinically relevant sources of mesenchymal stem cell-derived exosomes: Bone marrow and amniotic fluid. J Pediatr Surg. 2019 Jan; 54(1):86-90. View Abstract

  33. Donor mesenchymal stem cell linetics after transamniotic stem cell therapy (TRASCET) for experimental spina bifida. J Pediatr Surg. 2018 Jun; 53(6):1134-1136. View Abstract

  34. Regenerative medicine and spina bifida: Recent developments in induced fetal regeneration. J Pediatr Rehabil Med. 2017 12 11; 10(3-4):185-188. View Abstract

  35. Fetal bone marrow homing of donor mesenchymal stem cells after transamniotic stem cell therapy (TRASCET). J Pediatr Surg. 2017 Oct 12. View Abstract

  36. Transamniotic stem cell therapy: a novel strategy for the prenatal management of congenital anomalies. Pediatr Res. 2018 01; 83(1-2):241-248. View Abstract

  37. Donor mesenchymal stem cells home to maternal wounds after transamniotic stem cell therapy (TRASCET) in a rodent model. J Pediatr Surg. 2017 Jun; 52(6):1006-1009. View Abstract

  38. Comparisons of human amniotic mesenchymal stem cell viability in FDA-approved collagen-based scaffolds: Implications for engineered diaphragmatic replacement. J Pediatr Surg. 2017 Jun; 52(6):1010-1013. View Abstract

  39. Transamniotic stem cell therapy (TRASCET) in a leporine model of gastroschisis. J Pediatr Surg. 2017 Jan; 52(1):30-34. View Abstract

  40. A comparison between placental and amniotic mesenchymal stem cells for transamniotic stem cell therapy (TRASCET) in experimental spina bifida. J Pediatr Surg. 2016 Jun; 51(6):1010-3. View Abstract

  41. Transamniotic stem cell therapy (TRASCET) mitigates bowel damage in a model of gastroschisis. J Pediatr Surg. 2016 Jan; 51(1):56-61. View Abstract

  42. Trans-amniotic stem cell therapy (TRASCET) minimizes Chiari-II malformation in experimental spina bifida. J Pediatr Surg. 2015 Jun; 50(6):1037-41. View Abstract

  43. Extraluminal distraction enterogenesis using shape-memory polymer. J Pediatr Surg. 2015 Jun; 50(6):938-42. View Abstract

  44. Limb reconstruction with decellularized, non-demineralized bone in a young leporine model. Biomed Mater. 2015 Feb 10; 10(1):015021. View Abstract

  45. Partial or complete coverage of experimental spina bifida by simple intra-amniotic injection of concentrated amniotic mesenchymal stem cells. J Pediatr Surg. 2015 Jan; 50(1):69-73. View Abstract

  46. Operative indications in recurrent ileocolic intussusception. J Pediatr Surg. 2015 Jan; 50(1):126-30. View Abstract

  47. Extraluminal helicoidal stretch (Helixtretch): a novel method of intestinal lengthening. J Pediatr Surg. 2014 Dec; 49(12):1787-90. View Abstract

  48. The impact of gestational age on targeted amniotic cell profiling in experimental neural tube defects. Fetal Diagn Ther. 2015; 37(1):65-9. View Abstract

  49. Tissue engineering in congenital diaphragmatic hernia. Semin Pediatr Surg. 2014 Jun; 23(3):135-40. View Abstract

  50. A comparative analysis of human mesenchymal stem cell response to hypoxia in vitro: Implications to translational strategies. J Pediatr Surg. 2014 Jun; 49(6):915-8. View Abstract

  51. Targeted quantitative amniotic cell profiling: a potential diagnostic tool in the prenatal management of neural tube defects. J Pediatr Surg. 2013 Jun; 48(6):1205-10. View Abstract

  52. Intra-amniotic delivery of amniotic-derived neural stem cells in a syngeneic model of spina bifida. Fetal Diagn Ther. 2013; 34(1):38-43. View Abstract

  53. Pediatric postoperative intussusception in the minimally invasive surgery era: a 13-year, single center experience. J Am Coll Surg. 2013 Jun; 216(6):1089-93. View Abstract

  54. The amniotic fluid as a source of neural stem cells in the setting of experimental neural tube defects. Stem Cells Dev. 2013 Feb 15; 22(4):548-53. View Abstract

  55. Prenatal tracheal reconstruction with a hybrid amniotic mesenchymal stem cells-engineered construct derived from decellularized airway. J Pediatr Surg. 2012 Jun; 47(6):1072-9. View Abstract

  56. Craniofacial repair with fetal bone grafts engineered from amniotic mesenchymal stem cells. J Surg Res. 2012 Dec; 178(2):785-90. View Abstract

  57. Preclinical regulatory validation of an engineered diaphragmatic tendon made with amniotic mesenchymal stem cells. J Pediatr Surg. 2011 Jan; 46(1):57-61. View Abstract

  58. Serial amnioinfusions prevent fetal pulmonary hypoplasia in a large animal model of oligohydramnios. J Pediatr Surg. 2011 Jan; 46(1):67-71. View Abstract

  59. Amniotic and placental mesenchymal stem cell isolation and culture. Methods Mol Biol. 2011; 698:75-88. View Abstract

  60. Amniotic mesenchymal stem cells enhance normal fetal wound healing. Stem Cells Dev. 2011 Jun; 20(6):969-76. View Abstract

  61. Structural and biomechanical characteristics of the diaphragmatic tendon in infancy and childhood: an initial analysis. J Pediatr Surg. 2010 Jul; 45(7):1455-8. View Abstract

  62. Correlation between prenatal urinary matrix metalloproteinase activity and the degree of kidney damage in a large animal model of congenital obstructive uropathy. J Pediatr Surg. 2010 Jun; 45(6):1120-5. View Abstract

  63. Chest wall repair with engineered fetal bone grafts: an efficacy analysis in an autologous leporine model. J Pediatr Surg. 2010 Jun; 45(6):1354-60. View Abstract

  64. A large animal model of the fetal tracheal stenosis/atresia spectrum. J Surg Res. 2011 Nov; 171(1):164-9. View Abstract

  65. Prenatal urinary matrix metalloproteinase profiling as a potential diagnostic tool in fetal obstructive uropathy. J Pediatr Surg. 2010 Jan; 45(1):70-3. View Abstract

  66. Optical properties of human amniotic fluid: implications for videofetoscopic surgery. Fetal Diagn Ther. 2010; 27(2):87-90. View Abstract

  67. Sternal repair with bone grafts engineered from amniotic mesenchymal stem cells. J Pediatr Surg. 2009 Jun; 44(6):1120-6; discussion 1126. View Abstract

  68. Fetal tissue engineering. Clin Perinatol. 2009 Jun; 36(2):473-88, xii. View Abstract

  69. Differential risk for neonatal surgical airway intervention in prenatally diagnosed neck masses. J Pediatr Surg. 2009 Jan; 44(1):76-9. View Abstract

  70. Preservation of intestinal motility after the serial transverse enteroplasty procedure in a large animal model of short bowel syndrome. J Pediatr Surg. 2009 Jan; 44(1):229-35; discussion 235. View Abstract

  71. Neural stem cell delivery to the spinal cord in an ovine model of fetal surgery for spina bifida. Surgery. 2008 Sep; 144(3):367-73. View Abstract

  72. Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol. J Pediatr Surg. 2008 Jun; 43(6):1164-9. View Abstract

  73. Extracorporeal membrane oxygenation as a bridge to definitive tracheal reconstruction in neonates. J Pediatr Surg. 2008 May; 43(5):800-4. View Abstract

  74. Liver position is a prenatal predictive factor of prosthetic repair in congenital diaphragmatic hernia. Fetal Diagn Ther. 2008; 23(4):258-62. View Abstract

  75. Autologous Approaches to Tissue Engineering. StemBook. 2008. View Abstract

  76. A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells. Tissue Eng. 2007 Nov; 13(11):2633-44. View Abstract

  77. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J Pediatr Surg. 2007 Jun; 42(6):974-9; discussion 979-80. View Abstract

  78. Isolation of mesenchymal stem cells from amniotic fluid and placenta. Curr Protoc Stem Cell Biol. 2007 Jun; Chapter 1:Unit 1E.2. View Abstract

  79. Large fetal congenital cystic adenomatoid malformations: growth trends and patient survival. J Pediatr Surg. 2007 Feb; 42(2):404-10. View Abstract

  80. Ex utero intrapartum treatment with placement on extracorporeal membrane oxygenation for fetal thoracic masses. J Pediatr Surg. 2007 Feb; 42(2):420-5. View Abstract

  81. Ex utero intrapartum treatment with extracorporeal membrane oxygenation for severe congenital diaphragmatic hernia. J Pediatr Surg. 2007 Jan; 42(1):98-104; discussion 104-6. View Abstract

  82. Percent predicted lung volumes as measured on fetal magnetic resonance imaging: a useful biometric parameter for risk stratification in congenital diaphragmatic hernia. J Pediatr Surg. 2007 Jan; 42(1):193-7. View Abstract

  83. The second STEP: the feasibility of repeat serial transverse enteroplasty. J Pediatr Surg. 2006 Dec; 41(12):1951-6. View Abstract

  84. Fetal hepatic haematopoiesis is modulated by arterial blood flow to the liver. Br J Haematol. 2006 Aug; 134(3):330-2. View Abstract

  85. Postnatal myocardial augmentation with skeletal myoblast-based fetal tissue engineering. Surgery. 2006 Jul; 140(1):100-7. View Abstract

  86. Hyperoncotic enhancement of fetal pulmonary growth after tracheal occlusion: an alveolar and capillary morphometric analysis. J Pediatr Surg. 2006 Jul; 41(7):1214-8. View Abstract

  87. Fetal tracheal reconstruction with cartilaginous grafts engineered from mesenchymal amniocytes. J Pediatr Surg. 2006 Apr; 41(4):675-82; discussion 675-82. View Abstract

  88. Extracellular matrix dynamics associated with tissue-engineered intravascular sclerotherapy. J Pediatr Surg. 2006 Apr; 41(4):757-62. View Abstract

  89. Fetal cartilage engineering from amniotic mesenchymal progenitor cells. Stem Cells Dev. 2006 Apr; 15(2):245-53. View Abstract

  90. Serial transverse enteroplasty enhances intestinal function in a model of short bowel syndrome. Ann Surg. 2006 Feb; 243(2):223-8. View Abstract

  91. Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. J Pediatr Surg. 2006 Jan; 41(1):34-9; discussion 34-9. View Abstract

  92. Bronchial atresia: the hidden pathology within a spectrum of prenatally diagnosed lung masses. J Pediatr Surg. 2006 Jan; 41(1):61-5; discussion 61-5. View Abstract

  93. In vitro cartilage regeneration from proliferated adult elastic chondrocytes. Ann Plast Surg. 2005 Aug; 55(2):196-201. View Abstract

  94. Cartilage engineering from ovine umbilical cord blood mesenchymal progenitor cells. Stem Cells. 2005 Aug; 23(7):958-64. View Abstract

  95. Pneumonectomy in the mouse: technique and perioperative management. J Invest Surg. 2005 Jul-Aug; 18(4):201-5. View Abstract

  96. An injectable tissue-engineered embolus prevents luminal recanalization after vascular sclerotherapy. J Pediatr Surg. 2005 Jun; 40(6):920-5. View Abstract

  97. Enhancement of intravascular sclerotherapy by tissue engineering: short-term results. J Pediatr Surg. 2005 Feb; 40(2):412-7. View Abstract

  98. Intratracheal pulmonary ventilation improves gas exchange during laparoscopy in a pediatric lung injury model. J Pediatr Surg. 2005 Jan; 40(1):22-5. View Abstract

  99. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol. 2004 Dec; 18(6):877-91. View Abstract

  100. In situ inhibition of uterine activity by indomethacin: possible relevance to preterm labor prevention after fetal surgery. J Pediatr Surg. 2004 Aug; 39(8):1173-5. View Abstract

  101. Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. J Pediatr Surg. 2004 Jun; 39(6):834-8; discussion 834-8. View Abstract

  102. Rapidly polymerizing hydrogel prevents balloon dislodgement in a model of fetal tracheal occlusion. J Pediatr Surg. 2004 Apr; 39(4):557-60. View Abstract

  103. Hyperoncotic enhancement of pulmonary growth after fetal tracheal occlusion: a comparison between dextran and albumin. J Pediatr Surg. 2004 Mar; 39(3):324-8; discussion 324-8. View Abstract

  104. Local anesthetics inhibit uterine activity in vitro. Possible application on preterm labor prevention and treatment. Fetal Diagn Ther. 2003 Sep-Oct; 18(5):292-6. View Abstract

  105. Fetal tissue engineering: in vitro analysis of muscle constructs. J Pediatr Surg. 2003 Sep; 38(9):1348-53. View Abstract

  106. Fetal tissue engineering: chest wall reconstruction. J Pediatr Surg. 2003 Aug; 38(8):1188-93. View Abstract

  107. Serial transverse enteroplasty for short bowel syndrome: a case report. J Pediatr Surg. 2003 Jun; 38(6):881-5. View Abstract

  108. Fetal tracheal augmentation with cartilage engineered from bone marrow-derived mesenchymal progenitor cells. J Pediatr Surg. 2003 Jun; 38(6):984-7. View Abstract

  109. Tissue engineering: current state of clinical application. Curr Opin Pediatr. 2003 Jun; 15(3):267-71. View Abstract

  110. Fetal tissue engineering from amniotic fluid. J Am Coll Surg. 2003 Apr; 196(4):592-7. View Abstract

  111. Serial transverse enteroplasty (STEP): a novel bowel lengthening procedure. J Pediatr Surg. 2003 Mar; 38(3):425-9. View Abstract

  112. Clostridium botulinum toxin inhibits myometrial activity in vitro: possible application on the prevention of preterm labor after fetal surgery. J Pediatr Surg. 2003 Mar; 38(3):511-3. View Abstract

  113. Engineered fetal cartilage: structural and functional analysis in vitro. J Pediatr Surg. 2002 Dec; 37(12):1720-5. View Abstract

  114. The placenta as a cell source in fetal tissue engineering. J Pediatr Surg. 2002 Jul; 37(7):995-9; discussion 995-9. View Abstract

  115. Fetal tissue engineering: in utero tracheal augmentation in an ovine model. J Pediatr Surg. 2002 Jul; 37(7):1000-6; discussion 1000-6. View Abstract

  116. Positive intrapulmonary oncotic pressure enhances short-term lung growth acceleration after fetal tracheal occlusion. J Pediatr Surg. 2002 Jul; 37(7):1007-10; discussion 1007-10. View Abstract

  117. Ultrasound-guided fetal tracheal occlusion. J Pediatr Surg. 2002 Mar; 37(3):300-2. View Abstract

  118. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg. 2001 Nov; 36(11):1662-5. View Abstract

  119. Continuous intrapulmonary distension with perfluorocarbon accelerates lung growth in infants with congenital diaphragmatic hernia: initial experience. J Pediatr Surg. 2001 Aug; 36(8):1237-40. View Abstract

  120. Fetal tissue engineering: diaphragmatic replacement. J Pediatr Surg. 2001 Jan; 36(1):146-51. View Abstract

  121. The littlest patient. Sciences (New York). 1999 Jul-Aug; 39(4):34-8. View Abstract

  122. Prolonged local myometrial blockade prevents preterm labor after fetal surgery in a leporine model. J Pediatr Surg. 1999 Apr; 34(4):540-2. View Abstract

  123. Fetal response to neutral gas and liquid media for intraamniotic distension. J Pediatr Surg. 1999 Apr; 34(4):591-4. View Abstract

  124. Fetal carotid blood flow during videofetoscopy. J Pediatr Surg. 1998 Dec; 33(12):1737-40. View Abstract

  125. Insulin-like growth factor-I gene expression in three models of accelerated lung growth. J Pediatr Surg. 1998 Jul; 33(7):1057-60; discussion 1061. View Abstract

  126. Continuous intrapulmonary distension with perfluorocarbon accelerates neonatal (but not adult) lung growth. J Pediatr Surg. 1998 Feb; 33(2):292-8. View Abstract

  127. Videofetoscopically assisted fetal tissue engineering: skin replacement. J Pediatr Surg. 1998 Feb; 33(2):357-61. View Abstract

  128. Videofetoscopically assisted fetal tissue engineering: bladder augmentation. J Pediatr Surg. 1998 Jan; 33(1):7-12. View Abstract

  129. Management of biliary atresia in the liver transplantation era: a 15-year, single-center experience. J Pediatr Surg. 1998 Jan; 33(1):115-8. View Abstract

  130. ECMO in evolution: the impact of changing patient demographics and alternative therapies on ECMO. J Pediatr Surg. 1996 Aug; 31(8):1116-22; discussion 1122-3. View Abstract

  131. Resection of a massive sacrococcygeal teratoma using hypothermic hypoperfusion: a novel use of extracorporeal membrane oxygenation. J Pediatr Surg. 1995 Nov; 30(11):1557-9. View Abstract

  132. Fate of the reconstructed carotid artery after extracorporeal membrane oxygenation. J Pediatr Surg. 1995 Jul; 30(7):1046-9. View Abstract

  133. Experimental fetal tracheal ligation and congenital diaphragmatic hernia: a pulmonary vascular morphometric analysis. J Pediatr Surg. 1995 Jul; 30(7):917-23; discussion 923-4. View Abstract

  134. Congenital diaphragmatic hernia and associated anomalies: their incidence, identification, and impact on prognosis. J Pediatr Surg. 1994 Aug; 29(8):1113-7. View Abstract

  135. Surgically produced congenital diaphragmatic hernia in fetal rabbits. J Pediatr Surg. 1994 Jul; 29(7):882-6. View Abstract

  136. Antenatal diagnosis of isolated congenital diaphragmatic hernia is not an indicator of outcome. J Pediatr Surg. 1994 Jun; 29(6):815-9. View Abstract

  137. Experimental fetal tracheal ligation reverses the structural and physiological effects of pulmonary hypoplasia in congenital diaphragmatic hernia. J Pediatr Surg. 1994 Feb; 29(2):248-56; discussion 256-7. View Abstract

  138. [Liver transplantation in children: initial experience of the Instituto da Criança of the Hospital das Clínicas of Universidade de São Paulo]. AMB Rev Assoc Med Bras. 1991 Oct-Dec; 37(4):193-9. View Abstract

  139. [Acute abdomen in childhood caused by intestinal angiostrongylus infection: a case report]. AMB Rev Assoc Med Bras. 1990 Jul-Dec; 36(3-4):150-2. View Abstract

  140. [A new cannula for tracheostomy]. Rev Hosp Clin Fac Med Sao Paulo. 1988 Nov-Dec; 43(6):291-3. View Abstract

  141. [Prevention of tracheo-innominate fistula following tracheostomy: anatomic relations of the trachea and brachiocephalic trunk]. Rev Hosp Clin Fac Med Sao Paulo. 1988 Jan-Feb; 43(1):71-4. View Abstract
BESbswy
BESbswy